Allakos, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Carlos CA United States (2012)

Organization Overview

First Clinical Trial
2015
NCT02563938
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Allakos Inc. | Allakos, Inc.